http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003129160-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-204 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a8ce53b196b92dac77a82ee761ded0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd294a13f4e2901f14a2b119db595752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0de65df922a73cec6ba7dac3dfcaff0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7054688b1ca8a6ea03a1e1a504808a47 |
| publicationDate | 2003-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003129160-A1 |
| titleOfInvention | Use of Interleukin-6 |
| abstract | This invention relates to a method for chronic treatment of obesity wherein a pharmaceutically effective amount of a substance that upon administration to a patient without complete IL-6 deficiency will lead to an increased level of an IL-6 receptor agonist is administered to said patient for reducing adipose tissue mass. n Furthermore, the invention relates to the use of a substance that upon administration to a patient without complete IL-6 deficiency will lead to an increased level of an IL-6 receptor agonist for the production of a medicinal product for reducing adipose tissue mass for chronic treatment of obesity. |
| priorityDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 330.